T. Rowe Price Associates’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.14M | Buy |
|
|||||
|
2025
Q1 | $2.19M | Sell |
|
|||||
|
2024
Q4 | $25.6M | Sell |
|
|||||
|
2024
Q3 | $56.8M | Sell |
|
|||||
|
2024
Q2 | $55.9M | Sell |
|
|||||
|
2024
Q1 | $137M | Buy |
|
|||||
|
2023
Q4 | $174M | Buy |
|
|||||
|
2023
Q3 | $111M | Buy |
|
|||||
|
2023
Q2 | $148M | Buy |
|
|||||
|
2023
Q1 | $135M | Buy |
|
|||||
|
2022
Q4 | $73.3M | Sell |
|
|||||
|
2022
Q3 | $66.9M | Buy |
|
|||||
|
2022
Q2 | $60.6M | Buy |
|
|||||
|
2022
Q1 | $87.5M | Buy |
|
|||||
|
2021
Q4 | $160M | Buy |
|
|||||
|
2021
Q3 | $142M | Sell |
|
|||||
|
2021
Q2 | $208M | Buy |
|
|||||
|
2021
Q1 | $150M | Sell |
|
|||||
|
2020
Q4 | $121M | Buy |
|
|||||
|
2020
Q3 | $84.7M | Buy |
|
|||||
|
2020
Q2 | $34.8M | Buy |
|
|||||
|
2020
Q1 | $21.5M | Buy |
|
|||||
|
2019
Q4 | $14M | Sell |
|
|||||
|
2019
Q3 | $34.3M | Buy |
|